BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 4, 2011
View Archived Issues
Immunocytokine C2-2b-2b targets IFN-alpha-2b to tumor sites with enhanced antiproliferative activity
Read More
FDA approves Nexium I.V. for pediatric and adolescent patients with GERD
Read More
NanoViricides reports new data on FluCide candidates in model of lethal H1N1 influenza
Read More
12D03 targets mutant epidermal growth factor receptor and has antitumor activity
Read More
K-115 is safe and reduces intraocular pressure in clinical settings
Read More
Humanized MAb NEO-201 shows preclinical promise for treatment of solid tumors
Read More
New frizzled SMO receptor antagonist SEN-450 inhibits tumor growth in vivo
Read More
New GPR119 receptor modulators designed at IRM
Read More
Jenrin Discovery presents new cannabinoid CB1 receptor antagonists/inverse agonists
Read More
Novel antibacterial aminoglycoside analogues prepared by Achaogen
Read More
Karo Bio synthesizes new estrogen receptor-beta ligands
Read More
Methamphetamine-targeted dendribodies show no toxicity in vitro
Read More
Allergan discloses novel lysophospholipid S1P2 receptor antagonists
Read More
XOMA-3AB, a triple-antibody product against botulinum neurotoxin type A, enters phase I
Read More
Cell Therapeutics to resubmit NDA for pixantrone following review by FDA
Read More
Global Health Ventures advances with plans to conduct U.S. clinical trials of X-Excite
Read More
Biovista and Novartis enter research collaboration
Read More
Affinium Pharmaceuticals reports phase I data on AFN-1252
Read More
FDA grants priority review to Seattle Genetics' brentuximab vedotin BLAs
Read More
Seattle BioMed receives grant to identify biomarkers for malaria vaccine design
Read More
Synairgen's IFN-beta shows in vitro efficacy against bird flu
Read More
Lantheus provides FDA advisory committees with safety data for ultrasound contrast agent Definity
Read More
Teva Pharma to acquire Cephalon
Read More
Health Canada approves Vimovo
Read More
First patients with heart failure dosed in Nile Therapeutics' phase I cenderitide study
Read More
Otsuka Pharma begins phase I OPB-51602 study in hematological malignancies
Read More